首页> 外国专利> GROWTH FACTOR THERAPY MOBILIZATION OF STEM CELLS INTO THE PERIPHERAL BLOOD

GROWTH FACTOR THERAPY MOBILIZATION OF STEM CELLS INTO THE PERIPHERAL BLOOD

机译:干细胞生长因子治疗性动员为外周血

摘要

Stem cells are mobilized into the peripheral blood by a method comprising the steps of: (i) administering to an individual at least one of the following: FGFl and FGF2, and also at least one of the following: VEGF, VEGFA and VEGF 165; (ii) isolating the peripheral blood stem cells (PBSC) by apheresis; and (iii) injecting the PBSC into a patient suffering from chronic heart disease. Alternatively, gene therapy is used for the induction of the stem cells into the peripheral blood, wherein the gene therapy formulation comprises AD5FGF-4 or VEGF 165 plasmid DNA. Additionally, the progress of the treatment of the chronic heart disease is monitored by using an echocardiogram unit.
机译:通过包括以下步骤的方法将干细胞动员到外周血中:(i)向个体施用以下至少一种:FGF1和FGF2,以及还至少以下一种:VEGF,VEGFA和VEGF 165; (ii)通过血液分离术分离外周血干细胞(PBSC); (iii)将PBSC注射入患有慢性心脏病的患者。或者,将基因疗法用于将干细胞诱导到外周血中,其中所述基因疗法制剂包含AD5FGF-4或VEGF 165质粒DNA。另外,通过使用超声心动图仪监测慢性心脏病的治疗进展。

著录项

  • 公开/公告号EP1841462A4

    专利类型

  • 公开/公告日2009-12-23

    原文格式PDF

  • 申请/专利权人 FRANCO WAYNE;

    申请/专利号EP20060717336

  • 发明设计人 FRANCO WAYNE;

    申请日2006-01-04

  • 分类号A61K38;A61K35/12;A61K35/14;A61K35/28;A61K38/18;A61K45;A61K48;C12N5/0789;

  • 国家 EP

  • 入库时间 2022-08-21 18:40:30

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号